Package 31722-627-46

{"route": ["ORAL"], "spl_id": "3feb1c1a-c299-1862-e063-6394a90af07e", "openfda": {"nui": ["N0000008486"], "upc": ["0331722627269", "0331722627467"], "unii": ["563KS2PQY5"], "rxcui": ["993856"], "spl_set_id": ["bbd80370-3d23-41f8-8914-c6ea897c0154"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (31722-627-26)  / 200 mL in 1 BOTTLE", "package_ndc": "31722-627-26", "marketing_start_date": "20220531"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (31722-627-46)  / 465 mL in 1 BOTTLE", "package_ndc": "31722-627-46", "marketing_start_date": "20220531"}], "brand_name": "Lacosamide", "product_id": "31722-627_3feb1c1a-c299-1862-e063-6394a90af07e", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "31722-627", "dea_schedule": "CV", "generic_name": "Lacosamide", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lacosamide", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "10 mg/mL"}], "application_number": "ANDA209301", "marketing_category": "ANDA", "marketing_start_date": "20220531", "listing_expiration_date": "20261231"}